Evidence map›Paper›PMID 33788584›Full record

ArticleMolecular biology of the cell2021

Mps1 promotes poleward chromosome movements in meiotic prometaphase.

Régis E Meyer, Aaron R Tipton, Rebecca LaVictoire, Gary J Gorbsky, Dean S Dawson

Open access · bronzeAbstract read
In one paragraph

Article in Molecular biology of the cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Régis E MeyerProgram in Cell Cycle and Cancer Biology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Aaron R TiptonProgram in Cell Cycle and Cancer Biology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Rebecca LaVictoireProgram in Cell Cycle and Cancer Biology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Gary J GorbskyProgram in Cell Cycle and Cancer Biology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Dean S DawsonProgram in Cell Cycle and Cancer Biology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Oklahoma Medical Research Foundation · US

Funding

Understanding Cell DivisionR35GM126980 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GARY J. GORBSKY · 2018 to 2026
$3.7M
Orienting Chromosomes on the Meiotic SpindleR01GM110271 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI DAWSON, DEAN S · 2017 to 2017
$342k
NIGMS NIH HHS R01 GM110271NIGMS NIH HHS R35 GM126980
6 · The paper itself

Abstract

In prophase of meiosis I, homologous chromosomes pair and become connected by cross-overs. Chiasmata, the connections formed by cross-overs, enable the chromosome pair, called a bivalent, to attach as a single unit to the spindle. When the meiotic spindle forms in prometaphase, most bivalents are associated with one spindle pole and then go through a series of oscillations on the spindle, attaching to and detaching from microtubules until the partners of the bivalent become bioriented-attached to microtubules from opposite sides of the spindle. The conserved kinase, Mps1, is essential for the bivalents to be pulled by microtubules across the spindle in prometaphase. Here we show that

Indexed as

Cell PolarityChromosome PairingChromosomesKinetochoresMicrotubulesMutationPrometaphaseProtein Serine-Threonine KinasesSaccharomyces cerevisiae ProteinsSaccharomycetalesMPS1 protein, S cerevisiaeProtein Serine-Threonine KinasesSaccharomyces cerevisiae Proteins

Identifiers

PMID33788584
PMCPMC8101486
OpenAlexW3151008564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.